Literature DB >> 17438456

Mice depleted of alphabeta but not gammadelta T cells are resistant to mortality caused by cecal ligation and puncture.

Victor T Enoh1, Scott H Lin, Cheng Y Lin, Tracy Toliver-Kinsky, Erle D Murphey, Tushar K Varma, Edward R Sherwood.   

Abstract

The present study was undertaken to determine whether the mice depleted of alphabeta or gammadelta T cells show resistance to acute polymicrobial sepsis caused by cecal ligation and puncture (CLP). T-cell receptor beta knockout (betaTCRKO) and T-cell receptor delta knockout (deltaTCRKO) mice were used. An additional group of mice was treated with an antibody against the alphabeta T-cell receptor to induce alphabeta T-cell depletion; a subset of alphabeta T cell-deficient mice was also treated with anti-asialoGM1 to deplete natural killer (NK) cells. The mice underwent CLP and were monitored for survival, temperature, acid-base balance, bacterial counts, and cytokine production. The betaTCRKO mice and the wild-type mice treated with anti-beta T-cell receptor (anti-TCRbeta) antibody showed improved survival after CLP compared with wild-type mice. The treatment of alphabeta T cell-deficient mice with anti-asialoGM1further improved survival after CLP, especially when the mice were treated with imipenem. The improved survival observed in alphabeta T cell-deficient mice was associated with less hypothermia, improved acid-base balance, and decreased production of the proinflammatory cytokines interleukin (IL) 6 and macrophage inflammatory protein (MIP) 2. Compared with wild-type controls, the overall survival was not improved in deltaTCRKO mice. The concentrations of IL-6 and MIP-2 in plasma and cytokine mRNA expression in tissues were not significantly different between wild-type and deltaTCRKO mice. These studies indicate that mice depleted of alphabeta but not of gammadelta T cells are resistant to mortality in an acutely lethal model of CLP. The depletion of NK cells caused further survival benefit in alphabeta T cell-deficient mice. These findings suggest that alphabeta T and NK cells mediate or facilitate CLP-induced inflammatory injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438456     DOI: 10.1097/SHK.0b013e31802b5d9f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  21 in total

1.  Disorders of the immune system in severely burned patients.

Authors:  A D Fayazov; S I Shukurov; B I Shukurov; B C Sultanov; A N Namazov; D A Ruzimuratov
Journal:  Ann Burns Fire Disasters       Date:  2009-09-30

2.  Cecal ligation and puncture.

Authors:  Alex G Cuenca; Matthew J Delano; Kindra M Kelly-Scumpia; Lyle L Moldawer; Philip A Efron
Journal:  Curr Protoc Immunol       Date:  2010-11

Review 3.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

4.  Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock.

Authors:  Daniela S Herzig; Brandon R Driver; Geping Fang; Tracy E Toliver-Kinsky; Eric N Shute; Edward R Sherwood
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

5.  Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis.

Authors:  Kevin R Kasten; Priya S Prakash; Jacqueline Unsinger; Holly S Goetzman; Lisa G England; Cindy M Cave; Aaron P Seitz; Cristina N Mazuski; Tony T Zhou; Michel Morre; Richard S Hotchkiss; David A Hildeman; Charles C Caldwell
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

Review 6.  Roles of heat shock proteins and gamma delta T cells in inflammation.

Authors:  Mark I Hirsh; Wolfgang G Junger
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-19       Impact factor: 6.914

7.  Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.

Authors:  Charalambos Gogos; Antigone Kotsaki; Aimilia Pelekanou; George Giannikopoulos; Ilia Vaki; Panagiota Maravitsa; Stephanos Adamis; Zoi Alexiou; George Andrianopoulos; Anastasia Antonopoulou; Sofia Athanassia; Fotini Baziaka; Aikaterini Charalambous; Sofia Christodoulou; Ioanna Dimopoulou; Ioannis Floros; Efthymia Giannitsioti; Panagiotis Gkanas; Aikaterini Ioakeimidou; Kyriaki Kanellakopoulou; Niki Karabela; Vassiliki Karagianni; Ioannis Katsarolis; Georgia Kontopithari; Petros Kopterides; Ioannis Koutelidakis; Pantelis Koutoukas; Hariklia Kranidioti; Michalis Lignos; Konstantinos Louis; Korina Lymberopoulou; Efstratios Mainas; Androniki Marioli; Charalambos Massouras; Irini Mavrou; Margarita Mpalla; Martha Michalia; Heleni Mylona; Vassilios Mytas; Ilias Papanikolaou; Konstantinos Papanikolaou; Maria Patrani; Ioannis Perdios; Diamantis Plachouras; Aikaterini Pistiki; Konstantinos Protopapas; Kalliopi Rigaki; Vissaria Sakka; Monika Sartzi; Vassilios Skouras; Maria Souli; Aikaterini Spyridaki; Ioannis Strouvalis; Thomas Tsaganos; George Zografos; Konstantinos Mandragos; Phylis Klouva-Molyvdas; Nina Maggina; Helen Giamarellou; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2010-05-26       Impact factor: 9.097

8.  Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.

Authors:  Mohammad Mahabub-Uz Zaman; Kazuya Masuda; Kishan Kumar Nyati; Praveen Kumar Dubey; Barry Ripley; Kai Wang; Jaya Prakash Chalise; Mitsuru Higa; Hamza Hanieh; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

9.  Gammadelta T cells mitigate the organ injury and mortality of sepsis.

Authors:  Johannes Tschöp; André Martignoni; Holly S Goetzman; Lisa G Choi; Quan Wang; John G Noel; Cora K Ogle; Timothy A Pritts; Jay A Johannigman; Alex B Lentsch; Charles C Caldwell
Journal:  J Leukoc Biol       Date:  2007-12-06       Impact factor: 4.962

10.  CD4-expressing cells are early mediators of the innate immune system during sepsis.

Authors:  André Martignoni; Johannes Tschöp; Holly S Goetzman; Lisa G Choi; Maria D Reid; Jay A Johannigman; Alex B Lentsch; Charles C Caldwell
Journal:  Shock       Date:  2008-05       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.